Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.
Ribonucleotide reductase (RNR) provides the cell with a balanced supply of deoxyribonucleoside triphosphates (dNTP) for DNA synthesis. In budding yeast DNA damage leads to an up-regulation of RNR activity and an increase in dNTP pools, which are essential for survival. Mammalian cells contain three non-identical subunits of RNR; that is, one homodimeric large subunit, R1, carrying the catalytic site and two variants of the homodimeric small subunit, R2 and the p53-inducible p53R2, each containing a tyrosyl free radical essential for catalysis. S-phase-specific DNA replication is supported by an RNR consisting of the R1 and R2 subunits. In contrast, DNA damage induces expression of the R1 and the p53R2 subunits. We now show that neither logarithmically growing nor G(o)/G1-synchronized mammalian cells show any major increase in their dNTP pools after DNA damage. However, non-dividing fibroblasts expressing the p53R2 protein, but not the R2 protein, have reduced dNTP levels if exposed to the RNR-specific inhibitor hydroxyurea, strongly indicating that there is ribonucleotide reduction in resting cells. The slow, 4-fold increase in p53R2 protein expression after DNA damage results in a less than 2-fold increase in the dNTP pools in G(o)/G1 cells, where the pools are about 5% that of the size of the pools in S-phase cells. Our results emphasize the importance of the low constitutive levels of p53R2 in mammalian cells, which together with low levels of R1 protein may be essential for the supply of dNTPs for basal levels of DNA repair and mitochondrial DNA synthesis in G(o)/G1 cells.
Håkansson
Pelle
P
Department of Medical Biochemistry and Biophysics, Umeå University, SE-90187-Umeå, Sweden. pelle.hakanson@medchem.umu.se
Hofer
Anders
A
Thelander
Lars
L
D000818:Animals; D002384:Catalysis; D002453:Cell Cycle; D004247:DNA / Q000737:chemistry / Q000378:metabolism; D004249:DNA Damage; D004260:DNA Repair; D004261:DNA Replication; D004272:DNA, Mitochondrial / Q000378:metabolism; D003854:Deoxyribonucleotides / Q000737:chemistry*; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000378:metabolism; D005434:Flow Cytometry; D005609:Free Radicals; D016193:G1 Phase; D006918:Hydroxyurea / Q000737:chemistry; D015151:Immunoblotting; D051379:Mice; D008807:Mice, Inbred BALB C; D008928:Mitochondria / Q000378:metabolism; D041681:NIH 3T3 Cells; D011485:Protein Binding; D011994:Recombinant Proteins / Q000737:chemistry; D016192:Resting Phase, Cell Cycle; D012264:Ribonucleotide Reductases / Q000737:chemistry; D012265:Ribonucleotides / Q000737:chemistry*; D016196:S Phase; D004718:Saccharomycetales; D013997:Time Factors; D015854:Up-Regulation
D004272:DNA, Mitochondrial; D003854:Deoxyribonucleotides; D005609:Free Radicals; D011994:Recombinant Proteins; D012265:Ribonucleotides; D004247:DNA; D012264:Ribonucleotide Reductases; D006918:Hydroxyurea